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Background: There is excess mortality in patients(pts) with renal insufficiency (RI) and acute coronary syndrome (ACS) due to increased 
hemorrhagic & thrombotic risks. We evaluated the prognostic impact of management in pts with RI and ST or non-ST ACS in the FAST-MI 2010 
registry.
methods: FAST-MI is a nationwide French registry that included 4169 pts with AMI in 213 centres in 2010. Primary endpoint of this analysis was 
prognostic impact of management on in-hospital mortality.
results: Of the 4169 pts included (61% NSTEMI, 39% STEMI, age 65±14 years), 475(11.3%) had severe RI (creatinine clearance (CrCl) <=30 ml/
min), and 1111(26.7%) had moderate RI (CrCl 30-60 ml/min). RI pts were older, more often diabetic and more often had a history of respiratory 
insufficiency, heart failure and anemia. RI pts also had higher GRACE score, longer time to treatment and higher Killip class. RI pts less frequently 
received aspirin (94.4 vs 97.3% in non-RI pts; p<0.0001), thienopyridines (97.1 vs 99.7%; p<0.0001), GPIIb/IIIa inhibitors (25.1 vs 42.6%; 
p=0.0001) and less often underwent coronary angioplasty in-hospital (68.5 vs 84.1%, p<0.0001). In-hospital course of RI pts showed higher rates 
of BARC bleeding events (10.2 vs 6.5% vs non-RI pts; p<0.0001); stent thrombosis (0.76 vs 0.35%; p=0.07); LV ejection fraction (LVEF)<40% (27 
vs 14%; p<0.0001) and death (7.0% vs 0.54%; p<0.0001). In RI pts, multivariate analysis found LVEF<40% (OR 3.1, 95%CI [1.7-5.7]); STEMI (vs 
NSTEMI) (OR 4.67 [2.3-9.6]); Killip class >2 (OR 2.7 [1.4-5.4]); no thienopyridine (OR 3.5 [1.1-11.8]) and no revascularisation (OR 2.8 [1.5-5.2]) 
to be independent predictors of in-hospital mortality.
conclusions: RI is associated with excess in-hospital mortality in patients with ACS. This is due to suboptimal management, notably insufficient 
rates of revascularisation and thienopyridine therapy. Greater compliance with guidelines could improve outcomes in this population.
